Significance of hypoxia-inducible factor-1α expression with atrial fibrosis in rats induced with isoproterenol

Experimental and Therapeutic Medicine

Volumn 8, Issue 6, 2014, Pages 1677-1682

  Su, Fangju ^a   Zhang, Weize ^a   Chen, Yongqing ^a   Ma, Ling ^a   Zhang, Hanping ^a   Wang, Fei ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

Author keywords

Atrial; Fibrosis; Matrix metalloproteinase 9; Shypoxia inducible factor 1 ; Transforming growth factor 1

Indexed keywords

ANGIOTENSIN II; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOPRENALINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROMUSCULAR DYSPLASIA; HEART MUSCLE FIBROSIS; IMMUNOHISTOCHEMISTRY; MALE; MRNA EXPRESSION ASSAY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84908206534     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1989     Document Type: Article

References (29)

1. Meiltz A, Zimmermann M, Urban P, Bloch A; Association of Cardiologists of the Canton of Geneva: Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace 10: 674-680, 2008.
2. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ and Wolf PA: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271: 840-844, 1994.
3. Pan CH, Lin JL, Lai LP, Chen CL, Stephen Huang SK and Lin CS: Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation. FEBS Lett 581: 526-534, 2007.
4. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA and Maseri A: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96: 1180-1184, 1997.
5. Everett TH IV, Li H, Mangrum JM, et al: Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 102: 1454-1460, 2000.
6. Li D, Shinagawa K, Pang L, et al: Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104: 2608-2614, 2001.
7. Wang Z, Tang L, Zhu Q, et al: Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int 79: 300-310, 2011.
8. Zhang YG, Li YG, Liu BG, et al: Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Acta Pharmacol Sin 28: 36-43, 2007.
9. Hudson CC, Liu M, Chiang GG, et al: Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 22: 7004-7014, 2002.
10. Dong Y, Huang YF, Wang LQ and Chen B: Experimental study on the effects of rapamycin in prevention of rat corneal allograft rejection. Zhonghua Yan Ke Za Zhi 41: 930-935, 2005 (In Chinese).
11. Matsushita K, Wu Y, Okamoto Y, Pratt RE and Dzau VJ: Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 48: 1095-1102, 2006.
12. Zhang WZ, Wang ZG, Chen YQ, et al: Effects of valsartan and U0126 on atrial fibrosis and connexin40 remodeling in rats. Zhonghua Xin Xue Guan Bing Za Zhi 39: 1129-1134, 2011 (In Chinese).
13. Fine LG and Norman JT: Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 74: 867-872, 2008.
14. Copple BL, Kaska S and Wentling C: Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice. J Pharmacol Exp Ther 341: 307-316, 2012.
15. Rosmorduc O and Housset C: Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin Liver Dis 30: 258-270, 2010.
16. Ueno M, Maeno T, Nomura M, et al: Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 300: L740-L752, 2011.
17. Haase VH: Hypoxia-inducible factor signaling in the development of kidney fibrosis. Fibrogenesis Tissue Repair 5 Suppl 1: S16, 2012.
18. Thijssen VL, van der Velden HM, van Ankeren EP, et al: Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovasc Res 54: 427-437, 2002.
19. Gramley F, Lorenzen J, Jedamzik B, et al: Atrial fibrillation is associated with cardiac hypoxia. Cardiovasc Pathol 19: 102-111, 2010.
20. Rosenkranz S, Flesch M, Amann K, et al: Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol 283: H1253-H1262, 2002.
21. Lim JY, Park SJ, Hwang HY, et al: TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J Mol Cell Cardiol 39: 627-636, 2005.
22. Mihout F, Shweke N, Bigé N, et al: Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis. J Pathol 223: 37-45, 2011.
23. Higgins DF, Kimura K, Bernhardt WM, et al: Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117: 3810-3820, 2007.
24. Ogi H, Nakano Y, Niida S, et al: Is structural remodeling of fibrillated atria the consequence of tissue hypoxia? Circ J 74: 1815-1821, 2010.
25. Isobe K, Kuba K, Maejima Y, et al: Inhibition of endostatin/collagen XVIII deteriorates left ventricular remodeling and heart failure in rat myocardial infarction model. Circ J 74: 109-119, 2010.
26. Xu J, Cui G, Esmailian F, et al: Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 109: 363-368, 2004.
27. Nakano Y, Niida S, Dote K, et al: Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 43: 818-825, 2004.
28. Santibañez JF, Guerrero J, Quintanilla M, Fabra A and Martínez J: Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Commun 296: 267-273, 2002.
29. Zhang BB, Cai WM, Weng HL, et al: Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis. World J Gastroenterol 9: 2490-2496, 2003.